|
Section d6a, if implanted, give date: not applicable as the iol was removed and replaced during the same procedure.Section d6b, if explanted, give date: not applicable as the iol was removed and replaced during the same procedure.Therefore, not explanted.Section h3, device evaluated by manufacturer: the device has not been returned for evaluation.Therefore, a failure analysis of the complaint device cannot be completed.A review of the device history record and complaint trending will be performed.Upon completion of the review, if there is any further relevant information a supplemental medwatch will be filed.Attempts have been made to obtain the missing information.However, to date, it has not been received.All pertinent information available to johnson & johnson surgical vision, inc.Has been submitted.
|
|
It was reported that the johnson and johnson (jnj) intraocular lens (iol) was defective.The defect was noticed after the iol was inserted into the patient¿s eye.The iol was removed and replaced with a backup lens.There were no complications such as a capsule tear, vitrectomy incision enlargement, or sutures.No further information was provided.
|
|
Additional information: section d9: device available for evaluation? yes.Section d9: date returned to manufacturer: aug 19, 2025.Section h3: evaluated by manufacturer? yes.Device evaluation: the lens was visually inspected under magnification revealing that the lens was coated in viscoelastic residue.The lens was cleaned and inspected revealing that the haptics were bent and one haptic was detached.The lens was also damaged in the haptic region along with the radial hole.No further issues were identified.Based on the complaint investigation results, the product was released within specifications.Conclusion: as a result of the investigation there is no indication of a product quality deficiency, and the reported issue could not be verified.All pertinent information available to johnson & johnson surgical vision, inc.Has been submitted.
|